Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-150.72
Price to sales ratio
13.58

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
64
TMO
Thermo Fisher Scientific Inc Common Stock
630.84 USD-0.49%+0.98%+9.16%+29.04%233.25 B USD
106
DHR
Danaher Corporation Common Stock
215.78 USD+0.15%-0.09%+7.62%+5.04%151.69 B USD
357
A
Agilent Technologies, Inc. Common Stock
157.48 USD+1.49%-0.01%+11.55%+25.95%44.48 B USD
366
IQV
IQVIA Holdings, Inc. Common Stock
262.29 USD+0.28%+1.66%+8.38%+39.52%43.17 B USD

Frequently asked questions about Natera, Inc. Common Stock

What is the Natera, Inc. Common Stock stock price today?

The current price of Natera, Inc. Common Stock (NTRA) is 338.7. Over the past 24 hours, the stock has changed by +0.07%. Follow the NTRA chart for real-time price dynamics.

What is the stock ticker of Natera, Inc. Common Stock?

Natera, Inc. Common Stock trades under the ticker NTRA. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Natera, Inc. Common Stock stock going up?

NTRA has changed by +5.31% over the last week, +34.76% over the last month, and +104.23% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Natera, Inc. Common Stock?

Natera, Inc. Common Stock currently has a market capitalization of 48.82 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were Natera, Inc. Common Stock earnings last quarter?

Last quarter, Natera, Inc. Common Stock reported earnings of -0.47 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Natera, Inc. Common Stock revenue for the last quarter?

Natera, Inc. Common Stock reported quarterly revenue of 751.4 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

What was Natera, Inc. Common Stock net income for the last quarter?

Natera, Inc. Common Stock reported net income of -66.97 M for the last quarter. The previous quarter showed -85.09 M, which means net income changed by +21.30%.

How many employees does Natera, Inc. Common Stock have?

As of the latest available data, Natera, Inc. Common Stock has 6 140 employees. Workforce size can provide additional context about the company's scale and operations.

What is Natera, Inc. Common Stock EBITDA?

Natera, Inc. Common Stock EBITDA is -52.64 M, and its EBITDA margin is -7.01%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Natera, Inc. Common Stock stock?

You can buy Natera, Inc. Common Stock (NTRA) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Natera, Inc. Common Stock stock?

Investing in Natera, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the NTRA chart and related analysis on metatrader.com as part of your research.

Natera, Inc. - Common Stock

Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA testing technology, with a focus on women's health, cancer, and organ health. Natera's proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments in San Carlos, California and Austin, Texas.

News